Sign in

CIK 0001213037

  • Non-accelerated filer
  • Smaller reporting company

Cardiff Oncology, Inc.

Sign in to watch
Ticker
CRDF
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272004382
Phone
+1 858-952-7570
Business address
11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
Former names
Trovagene, Inc., TrovaGene Inc., XENOMICS INC, USED KAR PARTS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 65 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-03-11 Erlander Mark Chief Executive Officer Grant or award · Stock Options +758,400 2,925,098
2024-03-07 Erlander Mark Chief Executive Officer Grant or award · Stock Options +510,000 2,170,310
2023-03-15 Erlander Mark Chief Executive Officer Grant or award · Stock Options +482,064 1,664,477
2022-11-25 Erlander Mark Chief Executive Officer Purchase +10,000 $1.43 $14K 24,481
2022-03-09 Erlander Mark Chief Executive Officer Grant or award · Stock Options +370,128 1,185,400
2021-06-10 Erlander Mark Chief Executive Officer Grant or award · Stock Options +435,072 815,272
2021-03-23 Erlander Mark Chief Executive Officer Purchase +965 $10.34 $10K 14,481
2021-01-02 Erlander Mark Chief Executive Officer Option exercise +260 13,629
2021-01-02 Erlander Mark Chief Executive Officer Shares withheld for taxes −113 13,516
2021-01-02 Erlander Mark Chief Executive Officer Option exercise · Restricted Stock Units −260 0
2020-06-17 Erlander Mark Chief Executive Officer Grant or award · Stock Options +221,241 380,200
2020-05-14 Erlander Mark Chief Executive Officer Purchase +6,993 $1.43 $10K 13,369
2020-01-03 Erlander Mark Chief Scientific Officer Shares withheld for taxes −116 6,376
2020-01-03 Erlander Mark Chief Scientific Officer Shares withheld for taxes −552 6,231
2020-01-02 Erlander Mark Chief Scientific Officer Option exercise +261 6,492
2020-01-02 Erlander Mark Chief Scientific Officer Option exercise · Restricted Stock Units −261 260
2020-01-01 Erlander Mark Chief Scientific Officer Option exercise +1,250 6,783
2020-01-01 Erlander Mark Chief Scientific Officer Option exercise · Restricted Stock Units −1,250 521
2019-10-01 Erlander Mark Chief Scientific Officer Option exercise +1,250 5,999
2019-10-01 Erlander Mark Chief Scientific Officer Shares withheld for taxes −466 5,533

Page 1 of 3 · 60 trades